Children’s Tumor Foundation Chief Scientific Officer Dr. Kim Hunter-Schaedle has been invited by the Biotechnology Industry Organization (BIO) to present the Foundation’s translational neurofibromatosis programs in preclinical drug screening and clinical trials at the 12th Annual BIO CEO and Investors Conference (www.ceo.bio.org) at the Waldorf-Astoria Hotel in New York on February 9th at 9am. BIOtech Now’s Tracy Krughoff talked to Dr. Hunter-Schaedle to preview the BIO meeting: listen to the podcast at http://www.bio.org/podcasts/HunterSchaedle.wma
BIO Podcast Previews CTF Investor Conference Presentation
